The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (Apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer.
 
Toni K. Choueiri
Honoraria - NCCN; UpToDate
Consulting or Advisory Role - AVEO; Bayer; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); GlaxoSmithKline (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
 
Noah M. Hahn
Honoraria - D3 Oncology Solutions
Speakers' Bureau - Medivation
Research Funding - Abbott Laboratories (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Dendreon (Inst); Fluidigm (Inst); Genentech/Roche (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bionomics; Millennium
 
Ajjai Shivaram Alva
Honoraria - Eisai
Consulting or Advisory Role - Eisai
Research Funding - BIND Biosciences; Bristol-Myers Squibb; Genentech; Novartis; Oncogenex
 
Richard C. Lauer
No Relationships to Disclose
 
Robert Dreicer
No Relationships to Disclose
 
Joel Picus
No Relationships to Disclose
 
Roberto Pili
No Relationships to Disclose
 
Arjun Vasant Balar
No Relationships to Disclose
 
Guru Sonpavde
Consulting or Advisory Role - Bayer; Genentech; GlaxoSmithKline; Merck; Sanofi
Research Funding - Onyx (Inst)
 
Jean H. Hoffman-Censits
Research Funding - Sanofi
 
Elizabeth A. Guancial
No Relationships to Disclose
 
Robert Alter
No Relationships to Disclose
 
Meredith M. Regan
Research Funding - Celgene (Inst); Ferring (Inst); Ipsen (Inst); Merck (Inst); Novartis (Inst); OncoGenex (Inst); Pfizer (Inst); Veridex (Inst)
 
Cindy Jacobs
Employment - Oncogenex
Leadership - Oncogenex
Stock and Other Ownership Interests - Oncogenex
Travel, Accommodations, Expenses - Oncogenex; Teva
 
Patricia S. Stewart
Employment - Oncogenex
Stock and Other Ownership Interests - Oncogenex
Travel, Accommodations, Expenses - Oncogenex
 
Sumanta Kumar Pal
Honoraria - Medivation; Novartis
Consulting or Advisory Role - Aveo; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina; Merck
Honoraria - UpToDate
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Dendreon; Janssen Oncology; Johnson & Johnson; Lilly; Merck; Oncogenex; Onyx
Travel, Accommodations, Expenses - Genentech/Roche